soul trial oral semaglutide cardiovascular outcomes results 2024 nejm 2025 Presented at ACC.25: Among participants soul trial oral semaglutide cardiovascular

This feels very real to you despite others around you telling you that you look smaller and lighter

Ondansetron (48 mg as needed) is a serotonin 5-HT3 receptor antagonist that can be effective for GLP-1 agonist-related symptoms, though it may cause constipation, headache, and can prolong the QT interval in susceptible individuals

However, avoid antimotility agents during the first 23 weeks unless diarrhea severely impacts daily functionallowing your gut time to adapt naturally leads to better long-term tolerance

If you inject in the same body region, always use a different spot in that area each week

Doctors often recommend follow-up treatments along with healthy skin habits to prolong visible effects

Also, the use of contraceptive diaphragms and spermicides may change the normal bacterial environment around the urethra and make infection more likely